// App-Quantinova.ai

: Characterising individual response to mepolizumab treatment

Researchers

Presenter

  • David Jackson

Principal Investigators

  • Robert G Price

  • Steven W Yancey

  • Roland Buhl

  • Sally Wenzel

Medical Centers

  • Guy's Severe Asthma Center, Guy’s & St. Thomas’ NHS Trust & Asthma UK Centre, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom

  • Clinical Statistics, GSK, Stevenage, Hertfordshire, United Kingdom,

  • Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, United States.

  • Pulmonary Department, Mainz University Hospital, Mainz, Germany

  • University of Pittsburgh Asthma Institute at UPMC, Pittsburgh, United States of America

Locations

  • United Kingdom

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Recepteur d'Origine Nantais

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Open Label

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved